Moran Kyle

USNatural personCFO

Insider

Moran Kyle

USNatural personCFO

Transactions

Issuers

Buys / Sells

0/14

Last tx

09 Feb 2026

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Wave Life Sciences Ltd.	134,385	reported	09 Feb 2026	tx 40+1,969,505−691,068

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
05 Feb 2026	GRANT_AWARD	Wave Life Sciences Ltd.	45,625	0.00 USD
09 Feb 2026	SALE	Wave Life Sciences Ltd.	3,588	13.45 USD
05 Feb 2026	GRANT_AWARD	Wave Life Sciences Ltd.	273,750	0.00 USD	deriv
08 Dec 2025	EXERCISE	Wave Life Sciences Ltd.	60,000	2.83 USD
09 Dec 2025	SALE

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Wave Life Sciences Ltd.	134,385	reported	09 Feb 2026	tx 40+1,969,505−691,068

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
05 Feb 2026	GRANT_AWARD	Wave Life Sciences Ltd.	45,625	0.00 USD
09 Feb 2026	SALE	Wave Life Sciences Ltd.	3,588	13.45 USD
05 Feb 2026	GRANT_AWARD	Wave Life Sciences Ltd.	273,750	0.00 USD	deriv
08 Dec 2025	EXERCISE	Wave Life Sciences Ltd.	60,000	2.83 USD
09 Dec 2025	SALE